HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential Expression of the Angiotensin-(1-12)/Chymase Axis in Human Atrial Tissue.

AbstractBACKGROUND:
Heart chymase rather than angiotensin (Ang)-converting enzyme has higher specificity for Ang I conversion into Ang II in humans. A new pathway for direct cardiac Ang II generation has been revealed through the demonstration that Ang-(1-12) is cleaved by chymase to generate Ang II directly. Herein, we address whether Ang-(1-12), chymase messenger RNA (mRNA), and activity levels can be differentiated in human atrial tissue from normal and diseased hearts and if these measures associate with various pathologic heart conditions.
MATERIALS AND METHODS:
Atrial appendages were collected from 11 nonfailing donor hearts and 111 patients undergoing heart surgery for the correction of valvular heart disease, resistant atrial fibrillation, or ischemic heart disease. Chymase mRNA was analyzed by real-time polymerase chain reaction and enzymatic activity by high-performance liquid chromatography using Ang-(1-12) as the substrate. Ang-(1-12) levels were determined by immunohistochemical staining.
RESULTS:
Chymase gene transcripts, chymase activity, and immunoreactive Ang-(1-12) expression levels were higher in left atrial tissue compared with right atrial tissue, irrespective of cardiac disease. In addition, left atrial chymase mRNA expression was significantly higher in stroke versus nonstroke patients and in cardiac surgery patients who had a history of postoperative atrial fibrillation versus nonatrial fibrillation. Correlation analysis showed that left atrial chymase mRNA was positively related to left atrial enlargement, as determined by echocardiography.
CONCLUSIONS:
As Ang-(1-12) expression and chymase gene transcripts and enzymatic activity levels were positively linked to left atrial size in patients with left ventricular heart disease, an important alternate Ang II forming pathway, via Ang-(1-12) and chymase, in maladaptive atrial and ventricular remodeling in humans is uncovered.
AuthorsHao Wang, Jasmina Varagic, Sayaka Nagata, Neal D Kon, Sarfaraz Ahmad, Jessica L VonCannon, Kendra N Wright, Xuming Sun, Dwight Deal, Leanne Groban, Carlos M Ferrario
JournalThe Journal of surgical research (J Surg Res) Vol. 253 Pg. 173-184 (09 2020) ISSN: 1095-8673 [Electronic] United States
PMID32361612 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Peptide Fragments
  • RNA, Messenger
  • angiotensin-(1-12), human
  • Angiotensinogen
  • CMA1 protein, human
  • Chymases
Topics
  • Aged
  • Angiotensinogen (analysis, metabolism)
  • Animals
  • Atrial Fibrillation (epidemiology, pathology, physiopathology, surgery)
  • Chymases (analysis, genetics, metabolism)
  • Echocardiography
  • Female
  • Gene Expression Profiling
  • Heart Atria (diagnostic imaging, pathology, physiopathology, surgery)
  • Heart Valve Diseases (pathology, surgery)
  • Heart Ventricles (physiopathology)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Myocardial Ischemia (pathology, surgery)
  • Peptide Fragments (analysis, metabolism)
  • RNA, Messenger (isolation & purification, metabolism)
  • Stroke (epidemiology)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: